Technical Analysis for ONTX - Onconova Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.76 -2.22% -0.04
ONTX closed down 2.22 percent on Wednesday, September 18, 2019, on 34.72 times normal volume. It ran into resistance at its 50 day moving average. The bears made the stock sink to a new 52-week low. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ONTX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Slingshot Bearish Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Wide Range Bar Range Expansion 0.00%
Doji - Bearish? Reversal 0.00%
Doji - Bullish? Reversal 0.00%

Older signals for ONTX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. Its products include Rigosertib intravenous (IV) that is in Phase III trials for higher risk myelodysplastic syndromes (MDS); Rigosertib Oral, which is Phase II clinical trials for patients with transfusion-dependent lower risk MDS and in patients with head and neck cancers; and Rigosertib IV, a combination therapy with gemcitabine in a Phase III clinical trials for the treatment of patients with metastatic pancreatic cancer. The company's products also comprise ON 013105 that is in Phase I clinical trials to treat various lymphomas and leukemias; and Recilisib, a molecule with radiation protection properties has completed four Phase I clinical trials. In addition, its preclinical products consist of ON 1231320, an inhibitor of polo-like kinase 2; ON 123300, an inhibitor of the cell cycle and cancer cell metabolism; ON 108600, an inhibitor of cyclin-dependent kinase 9 and casein kinase 2; ON 044580, a dual inhibitor of janus kinase 2 and Bcr-Abl kinase; ON 24 series of compounds that are oral anti-tubulin agents; and ON 146 series, which are selective inhibitors of PI3K alpha/delta isoforms. The company was founded in 1998 and is headquartered in Newtown, Pennsylvania.
Biopharmaceutical Cancer Chemical Compounds Organic Compounds Radiation Myelodysplastic Syndrome Pyridines Tyrosine Kinase Inhibitors Bemcentinib Protein Kinase Inhibitors Lymphomas Head And Neck Cancers Kinase Leukemias Metastatic Pancreatic Cancer Heterocyclic Compounds Piperazines
Is ONTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.17
52 Week Low 1.65
Average Volume 133,962
200-Day Moving Average 3.0991
50-Day Moving Average 2.3986
20-Day Moving Average 2.3613
10-Day Moving Average 2.3915
Average True Range 0.2889
ADX 20.67
+DI 30.3064
-DI 22.7317
Chandelier Exit (Long, 3 ATRs ) 1.9733
Chandelier Exit (Short, 3 ATRs ) 2.5167
Upper Bollinger Band 2.8616
Lower Bollinger Band 1.861
Percent B (%b) -0.1
BandWidth 42.374963
MACD Line -0.0913
MACD Signal Line -0.0217
MACD Histogram -0.0696
Fundamentals Value
Market Cap 17.33 Million
Num Shares 9.85 Million
EPS -2.57
Price-to-Earnings (P/E) Ratio -0.68
Price-to-Sales 9.36
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.35
Resistance 3 (R3) 3.49 3.10 3.09
Resistance 2 (R2) 3.10 2.70 3.03 3.00
Resistance 1 (R1) 2.43 2.44 2.77 2.29 2.91
Pivot Point 2.04 2.04 2.21 1.97 2.04
Support 1 (S1) 1.37 1.64 1.71 1.23 0.61
Support 2 (S2) 0.98 1.38 0.91 0.52
Support 3 (S3) 0.31 0.98 0.44
Support 4 (S4) 0.17